UPDATE 1-Rigel experimental eye drug fails mid-stage study
August 13, 2014 at 08:19 AM EDT
Aug 13 (Reuters) - Rigel Pharmaceuticals Inc said its experimental drug failed to meet the main goal in a mid-stage study in patients with dry eye disease, sending its shares down 10.7 percent in premarket trading.
